The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
Official Title: Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
Study ID: NCT03752203
Brief Summary: Sodium fluorescein, which has been shown to be useful for intraoperative guidance regarding the resection of adult neurosurgical tumors, can aid the resection of pediatric neurosurgical tumors.
Detailed Description: This study will be a prospective non-randomized cohort study with patients presenting to Children's Hospital Colorado for resection of a central nervous system tumor. This study will employ the use of sodium fluorescein and an FDA approved operative microscope equipped with excitation and barrier filters for monitoring with sufficient fluorescent enhancement and contrast. Fluorescein sodium is a small organic salt that accumulates in areas of diminished blood-brain barrier integrity and allows for determination of the margins between tumor and normal brain function.
Minimum Age: 31 Days
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Children's Hospital Colorado, Aurora, Colorado, United States
Name: Todd Hankinson, MD
Affiliation: Children's Hospital Colorado
Role: PRINCIPAL_INVESTIGATOR